Treating BCG-induced disease in children
Source: Cochrane
Area: Evidence > Disease Focused Reviews
Background
Bacillus Calmette-Guerín (BCG) is a live attenuated vaccine to prevent tuberculosis, routinely administered at birth as part of the World Health Organization global expanded immunisation programme. Given intradermally, it can cause adverse reactions, including local, regional, distant and disseminated manifestations that may cause parental distress. Rarely, it can cause serious illness and even death. Among those patients with immunocompromised conditions, such as the human immunodeficiency virus (HIV) infection, the complication rate is even higher.
Objectives
To assess the effects of different interventions for treating BCG-induced disease in children.
Search methods
The following databases were searched: the Cochrane Infectious Diseases Group Specialized Register and Cochrane Central Register of Controlled Trials (CENTRAL), published in The Cochrane Library (The Cochrane Library 2012, Issue 4); MEDLINE (1966 to November ...
Source: NeLM - Disease Focused Reviews - Category: Internal Medicine Source Type: news
More News: Children | Databases & Libraries | Health | Infectious Diseases | Internal Medicine | International Medicine & Public Health | Tuberculosis | Vaccines | WHO